ESCMID weekly news 17.12.2019

17 December 2019: ESCMID Weekly News
Having trouble viewing this email? View in your browser.


17 December 2019

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.


ESCMID Postgraduate Technical Workshop in Vienna – Technical Hospital Hygiene

Don’t miss the ESCMID Postgraduate Technical Workshop “Technical hospital hygiene – Tricks of the trade” to be held in Vienna from 6 – 8 February 2020.

View the programme and other details
online here

Visit the
ESCMID courses website to register for this and other great ESCMID Courses and Workshops.

› Read more

Second ESCMID Course on Zoonosis – Grants Available!

Registrations and Grant applications are now being collected for the Second ESCMID Course on Zoonosis, to be held in Saint Maxime, France, from 30 September – 2 October 2020.

Join an expert faculty as they discuss a wide variety of animal-borne diseases, and the current state of zoonoses in Europe and beyond.

Find this and other great ESCMID courses and workshops on the ESCMID Courses Website.

› Read more

Join us at ECCMID 2020 to experience the Symposium
“Making most of our new arsenal: approval and use of recently launched antibiotics” co-organized by EPASG (ESCMID PK/PD of Anti-Infectives Study Group), ESGAP (ESCMID Study Group for Antimicrobial Stewardship) and GARDP (Global Antibiotic Research & Development Partnership)

Speakers: Astrid Pentz-Murr, Jean-Pierre Paccaud,
Markus Zeitlinger, Céline Pulcini

Several novel antibiotics made it to the market in the last years and more are waiting in the starting blocks. Novel approval pathways like the change from indication- to pathogen-driven approvals have become reality. This session describes several steps needed for the identification and the application of new antibiotics, from R&D to integration in stewardship concepts. The first talk is about an educational initiative of the GARDP to facilitate R&D. The second talk gives perspective on the economical efforts needed to develop new antibiotics. The third talk focuses on the implications of the approval process for clinical use of novel drugs. Finally, the last presentation gives practical advice on how novel antibiotics should be implemented in stewardship concepts, finding the balance between restrictive use of new drugs and the need for more experience.

ECCMID Live to discover more about our scientific programme and register now to take advantage of early registration discounts!

› Read more


ESCMID and FEMS: happy together (again)!

The Federation of European Microbiological Societies (FEMS) and ESCMID agreed to officially renovate the Memorandum of Understanding (MoU) between the two societies, a reflection of the good will and mutual interest that exists between the two organizations.
The just-signed MoU will strengthen joint activities to promote science and education in the field of clinical microbiology and infectious diseases.


Via ESGARS: WHO CAESAR Annual Report 2019

The Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) Report 2019 is now available at the WHO website.

The ESCMID Study group for Antimicrobial Resistance Surveillance (ESGARS) were heavily involved in the compilation of the report. 

› Read more


ESCMID is happy to announce the recipients of the prestigious ESCMID Awards for the year 2020. Congratulations!

ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases

The ESCMID Executive Committee unanimously chose
Prof. Herman Goossens (University of Antwerp, Antwerpen, Belgium) as the recipient of the 2020 ESCMID Award for Excellence in Clinical Microbiology and Infectious Diseases in recognition of his outstanding contributions in the field of antibiotic stewardship and resistance. Prof. Goossens will receive his award at ECCMID 2020 in Paris during the Excellence Award session on Monday 20 April 2020. During the ceremony, he will give his recipient lecture entitled “Transcending European clinical research in infectious diseases through collaboration to break down traditional silos”.

ESCMID Young Investigator Awards for Research in Clinical Microbiology and Infectious Diseases

We are very pleased to communicate the three recipients of the 2020 ESCMID Young Investigator Award for Research in Clinical Microbiology and Infectious Diseases in recognition of their extraordinary achievements:

Dr Paolo Miotto (Milan, Italy)

Dr Norbert Pardi (Philadelphia, United States)

Dr Niccolò Buetti (Bern, Switzerland)

The awards will be presented at ECCMID 2020 in Paris and the recipients will give an honorary talk in the Symposium Young Investigator Award Lectures on Sunday 19 April 2020.

Further, we are very pleased to announce the two recipients of the 2020 ESCMID TAE Outstanding Trainee Award in Clinical Microbiology and Infectious Diseases:

Dr Parul Kodan (Delhi, India)

Mr Carlos L. Correa-Martínez (Münster, Germany)

The awards will be handed over during TAE Day 2020 at next ECCMID in Paris on Sunday 19 April 2020.

› Read more


CMI Highlight: Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries

In 2017, the World Health Organization (WHO) published a global priority list of 12 antibiotic-resistant bacteria (ARB) in urgent need of new antibiotics. N. Rajendran et al aimed to identify and assess publicly-accessible mandatory surveillance systems and outbreaks reporting for these pathogens in the 28 European Union and 4 European Free Trade Association member states. Compulsory reporting was mapped by reviewing national documents without applying language restrictions and through experts’ consultation. Information on surveillance targets, indicators, metrics, and dissemination modalities were extracted and a qualitative assessment performed for open access systems only.

This review shows that despite the increasing burden of ARB on the European population, only a very few countries implemented mandatory surveillance and outbreak reporting of the WHO priority pathogens. Less than half of the European countries (47%) implemented publicly-accessible mandatory surveillance of at least one antibiotic-resistant bacterium among the 12 pathogens identified by WHO as in urgent need of new therapies. International efforts are needed to define the effectiveness of implementing mandatory reporting of these pathogens and assess their role in reducing the spread of ARB in healthcare and community settings.

› Read more

ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube

The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.